Droia Invest Ii Scsp - Net Worth and Insider Trading

Droia Invest Ii Scsp Net Worth

The estimated net worth of Droia Invest Ii Scsp is at least $11 Million dollars as of 2024-05-03. Droia Invest Ii Scsp is the 10% Owner of Cyteir Therapeutics Inc and owns about 3,536,803 shares of Cyteir Therapeutics Inc (CYTT) stock worth over $11 Million. Details can be seen in Droia Invest Ii Scsp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Droia Invest Ii Scsp has not made any transactions after 2021-06-22 and currently still holds the listed stock(s).

Transaction Summary of Droia Invest Ii Scsp

To

Droia Invest Ii Scsp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Droia Invest Ii Scsp owns 1 companies in total, including Cyteir Therapeutics Inc (CYTT) .

Click here to see the complete history of Droia Invest Ii Scsp’s form 4 insider trades.

Insider Ownership Summary of Droia Invest Ii Scsp

Ticker Comapny Transaction Date Type of Owner
CYTT Cyteir Therapeutics Inc 2021-06-22 10 percent owner

Droia Invest Ii Scsp Latest Holdings Summary

Droia Invest Ii Scsp currently owns a total of 1 stock. Droia Invest Ii Scsp owns 3,536,803 shares of Cyteir Therapeutics Inc (CYTT) as of June 22, 2021, with a value of $11 Million.

Latest Holdings of Droia Invest Ii Scsp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYTT Cyteir Therapeutics Inc 2021-06-22 3,536,803 3.01 10,645,777

Holding Weightings of Droia Invest Ii Scsp


Droia Invest Ii Scsp Form 4 Trading Tracker

According to the SEC Form 4 filings, Droia Invest Ii Scsp has made a total of 1 transactions in Cyteir Therapeutics Inc (CYTT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cyteir Therapeutics Inc is the acquisition of 277,777 shares on June 22, 2021, which cost Droia Invest Ii Scsp around $5 Million.

Insider Trading History of Droia Invest Ii Scsp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Droia Invest Ii Scsp Trading Performance

GuruFocus tracks the stock performance after each of Droia Invest Ii Scsp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Droia Invest Ii Scsp is -13.79%. GuruFocus also compares Droia Invest Ii Scsp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Droia Invest Ii Scsp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Droia Invest Ii Scsp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Droia Invest Ii Scsp

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -17.85
Relative Return to S&P 500(%) -20.7

Droia Invest Ii Scsp Ownership Network

Ownership Network List of Droia Invest Ii Scsp

No Data

Ownership Network Relation of Droia Invest Ii Scsp


Droia Invest Ii Scsp Owned Company Details

What does Cyteir Therapeutics Inc do?

Who are the key executives at Cyteir Therapeutics Inc?

Droia Invest Ii Scsp is the 10 percent owner of Cyteir Therapeutics Inc. Other key executives at Cyteir Therapeutics Inc include 10 percent owner Novo Holdings A/s , General Counsel Adam M Veness , and Chief Business Officer Andrew Gengos .

Cyteir Therapeutics Inc (CYTT) Insider Trades Summary

Over the past 18 months, Droia Invest Ii Scsp made no insider transaction in Cyteir Therapeutics Inc (CYTT). Other recent insider transactions involving Cyteir Therapeutics Inc (CYTT) include a net sale of 418,277 shares made by Novo Holdings A/s , a net purchase of 170,589 shares made by Braden Michael Leonard , and a net purchase of 21,202 shares made by Joseph S Zakrzewski .

In summary, during the past 3 months, insiders sold 0 shares of Cyteir Therapeutics Inc (CYTT) in total and bought 170,589 shares, with a net purchase of 170,589 shares. During the past 18 months, 418,277 shares of Cyteir Therapeutics Inc (CYTT) were sold and 191,791 shares were bought by its insiders, resulting in a net sale of 226,486 shares.

Cyteir Therapeutics Inc (CYTT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cyteir Therapeutics Inc Insider Transactions

No Available Data

Droia Invest Ii Scsp Mailing Address

Above is the net worth, insider trading, and ownership report for Droia Invest Ii Scsp. You might contact Droia Invest Ii Scsp via mailing address: 28 Boulevard Joseph Ii, Luxembourg N4 L-1840.

Discussions on Droia Invest Ii Scsp

No discussions yet.